Elevated blood pressure in subjects with lipodystrophy

Area of Science:

• Endocrinology
• Cardiology
• Infectious Diseases

Background:

• Lipodystrophy is associated with metabolic abnormalities.
• Patients with HIV often experience metabolic complications, including dyslipidemia.
• Elevated blood pressure is a significant cardiovascular risk factor.

Purpose of the Study:

• To determine the prevalence of elevated blood pressure in patients with lipodystrophy.
• To compare blood pressure readings between HIV-positive patients with lipodystrophy and controls.
• To investigate potential correlations between blood pressure and metabolic factors in HIV-positive individuals.

Main Methods:

• A case-control study was conducted.
• Forty-two HIV-positive patients with lipodystrophy were matched with 42 HIV-positive controls and 13 HIV-negative controls.
• Blood pressure was monitored over an extended period, and measurements were analyzed for frequency, magnitude, and correlation with anthropometric and lipid parameters.

Main Results:

• Elevated blood pressure readings occurred significantly more often in the HIV-positive lipodystrophy cohort (74%) compared to HIV-positive controls (48%).
• The cohort exhibited higher average systolic (153 mmHg) and diastolic (92 mmHg) blood pressure readings than controls.
• Systolic blood pressure correlated with waist-to-hip ratio in the lipodystrophy cohort, suggesting a link to body fat distribution.

Conclusions:

• Elevated blood pressure is more prevalent in HIV-positive patients with lipodystrophy.
• These findings suggest that metabolic disorders, similar to those in dysmetabolic syndrome, may contribute to hypertension in HIV patients.
• Further research is warranted to elucidate the mechanisms linking lipodystrophy, HIV, and hypertension.